Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 2, 2015Expert Opinion on Emerging Drugs

Emerging drugs for the treatment of axial and peripheral spondyloarthritis

View Full Paper
Ask AI
Bookmark
Share

Authors

JBJuergen BraunRuhr University BochumUKUta KiltzRheumazentrum RuhrgebietFHF. HeldmannKlinikum Chemnitz

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Braun et al. (2015) studied this question.

synapsesocial.com/papers/6aa26d1cd3d42046dea582d4https://doi.org/10.1517/14728214.2015.993378
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Predicting the outcome of ankylosing spondylitis therapy2011 · 190 citations
  2. 2Tumor necrosis factor alpha antagonists in the treatment of axial spondyloarthritis2014 · 26 citations
  3. 3Treatment of ankylosing spondylitis in patients refractory to TNF-inhibition2012 · 36 citations
  4. 4Secukinumab induction and maintenance therapy in moderate-to-severe plaque psoriasis: a randomized, double-blind, placebo-controlled, phase II regimen-finding study2013 · 244 citations